Skip to content

Clinical trials

Phase 2 Breast Neoplasms trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 2 Status: Unknown status Clear all

362 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
20021
20037
20043
20057
200613
200711
200811
20096
201011
201118
201210
201313
201420
201523
201623
201712
201815
201933
202027
202125
202231
202317
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status362

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University28
Chinese Academy of Medical Sciences18
Sun Yat-sen University10
National University Hospital, Singapore7
Zhejiang Cancer Hospital7
Cancer Institute and Hospital, Chinese Academy of Medical Sciences5
Consorzio Oncotech5
National Cancer Center, Korea5
Royal Marsden NHS Foundation Trust5
Shandong Cancer Hospital and Institute5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms362
Triple Negative Breast Neoplasms21
Neoplasm Metastasis17
Brain Neoplasms10
Neoplasms10
Carcinoma, Non-Small-Cell Lung6
Pathologic Complete Response6
Breast Neoplasms, Male5
Stomach Neoplasms5
Colorectal Neoplasms4

Trials

Showing 1 to 25 of 362. Each trial links to its page on Pharma Observatory.

262 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.